Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J.L. Heerspink, Rey Isidto, Tom Greene et al.|Nephrology Dialysis Transplantation|2019Cited by 216
Baseline, Early Changes, and Residual AlbuminuriaDominique van Mil, Hiddo J.L. Heerspink, Priya Vart et al.|Clinical Journal of the American Society of Nephrology|2024Cited by 10